Selected Publications
Yu, K., Wild, K., Dowling, M., Kaye, J. A., Silbert, L. C., & Dodge, H. H. Emotional Characteristics of Socially Isolated Older Adults with MCI Using Tablet Administered NIH Toolbox: I-CONECT study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. Forthcoming.
​
Tang F, Chen J, Dodge HH, Zhou J. The Joint Effects of Acoustic and Linguistic Markers for Early Identification of Mild Cognitive Impairment. Frontiers in Digital Health. 2022;3. https://doi.org/10.3389/fdgth.2021.702772 (PMID: 35224534, PMC8878676)
Wu CY, Mattek N, Wild K, Miller LM, Kaye JA, Silbert LC, Dodge HH. Can Changes in Social Contact (Frequency, Mode) Mitigate Low Mood Before and During the COVID-19 pandemic? I-CONECT Project. J Am Geriatr Soc. 2022;70(3):669-676. doi:10.1111/jgs.17607. (PMID: 34881436, PMC8904274).
Yu K, Wild K, Potempa K, Hampstead BM, Lichtenberg PA, Struble LM, Pruitt P, Alfaro EL, Lindsley J, MacDonald M, Kaye JA, Silbert LC and Dodge HH. The Internet-Based Conversational Engagement Clinical Trial (I-CONECT) in Socially Isolated Adults 75+ Years Old: Randomized Controlled Trial Protocol and COVID-19 Related Study Modifications. Front. Digit. Health 3:714813. doi: 10.3389/fdgth.2021.714813. (PMC8521795)
Peters R, James S, Jicha GA, Meyer PF, Marcus R, Smith DA, Yassine HN, Abner E, Hainsworth AH, PG Kehoej, Beckett N, Anderson C, Anstey KJ. Dodge HH. Dementia risk reduction, why haven’t the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. 2021;7:e12202. ttps://doi.org/10.1002/trc2.12202 (PMC8655351).
​
Dodge HH, Goldstein FC, Wakim N, Gefen T, Teylan M, Chan CG K, Kukull WA, Barnes LL, Giordani B, Hughes TM, Kramer JH, Loewenstein DA, Marson DC, Mungas DM, Mattek N, Sachs BC, Salmon DP, Willis-Parker M, Welsh-Bohmer KA, Wild KV, Morris JC, Weintraub S, and National Alzheimer's Coordinating Center (NACC). Differentiating among Stages of Cognitive Impairment in Aging: Comparisons of Versions 2 and 3 of the National Alzheimer’s Coordinating Center (NACC). Alzheimer’s Dement. 2020;6:e12103 (PMID: 33283037 PMCID: 7683960)
Wakim, N., Braun, T.M., Kaye, J.A., and Dodge, H.H. for ORCATECH. Choosing the right time granularity for analysis of digital biomarker trajectories. Alzheimers Dement (N Y): 2020 Dec 18;6(1):e12094. doi: 10.1002/trc2.12094. (PMID: 33354618, PMC7748028)
Dodge HH, Estrin D. Making Sense of Aging with Data Big and Small. The Bridge: The Journal of National Academy of Engineering. 2019, Volume 49, No.1, p40-46.
Dodge HH, Zhu J, Mattek NC, Austin D, Kornfeld J, Kaye JA: Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials. PLoS One 10(9): e0138095, 2015. PM26379170/PMC4574479
Dodge HH, Zhu J, Mattek N, Bowman M, Ybarra O, Wild K, Loewenstein DA, Kaye JA: Web-enabled Conversational Interactions as a Means to Improve Cognitive Functions: Results of a 6-Week Randomized Controlled Trial. Alzheimers & Dementia : Translational Research and Clinical Interventions 1(1): 1-12, 2015. PM26203461/PMC4507295
Dodge HH, Zhu J, Lee CW, Chang CC, Ganguli M: Cohort effects in age-associated cognitive trajectories J. Gerontol. A Biol. Sci. Med. Sci. 69(6): 687-694, 2014. PM24270062/PMC4022091
Dodge HH, Ybarra O, Kaye JA: Tools for advancing research into social networks and cognitive function in older adults Int Psychogeriatr 26(4): 533-539, 2014. PM24152936/PMC3654367
Dodge HH, Katsumata Y, Zhu J, Mattek N, Bowman M, Gregor M, Wild K, Kaye JA: Characteristics associated with willingness to participate in a randomized controlled behavioral clinical trial using home-based personal computers and a webcam. Trials 15: 508, 2014. PM25539637/PMC4307639
Dodge HH, Zhu J, Harvey D, Saito N, Silbert LC, Kaye JA, Koeppe RA, Albin RL, Alzheimer's Disease Neuroimaging Initiative: Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease. Alzheimer's & dementia : the journal of the Alzheimer's Association 10(6): 690-703, 2014. PM25022534/PMC4253728
Dodge HH, Buracchio TJ, Fisher GG, Kiyohara Y, Meguro K, Tanizaki Y, Kaye JA: Trends in the prevalence of dementia in Japan. International Journal of Alzheimer's Disease 2012: 956354, 2012. PM23091769/PMC3469105
Dodge HH, Wang CN, Chang CC, Ganguli M: Terminal decline and practice effects in older adults without dementia: the MoVIES project. Neurology 77(8): 722-30, 2011. PM21832224/PMC3164394
Dodge HH, Katsumata Y, Todoriki H, Yasura S, Willcox DC, Bowman GL, Willcox B, Leonard S, Clemons A, Oken BS, Kaye JA, Traber MG: Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 65(10): 1060-7, 2010. PM20643702/PMC3031451
Dodge HH, Zitzelberger T, Oken BS, Howieson D, Kaye J: A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 70(19 Pt 2): 1809-17, 2008. PM18305231/PMC2639649
Dodge HH, Kadowaki T, Hayakawa T, Yamakawa M, Sekikawa A, Ueshima H: Cognitive impairment as a strong predictor of incident disability in specific ADL-IADL tasks among community-dwelling elders: the Azuchi Study. The Gerontologist 45(2): 222-30, 2005. PM15799987
Dodge HH, Shen C, Pandav R, DeKosky ST, Ganguli M: Functional transitions and active life expectancy associated with Alzheimer disease. Archives of Neurology 60(2): 253-9, 2003. PM12580712
​